DSGN icon

Design Therapeutics

95 hedge funds and large institutions have $108M invested in Design Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership:

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less capital invested

Capital invested by funds: $124M → $108M (-$16.4M)

93% less call options, than puts

Call options by funds: $5K | Put options by funds: $75K

Holders
95
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5K
Puts
$75K
Net Calls
Net Calls Change

Top Sellers

1 -$1.91M
2 -$1.53M
3 -$517K
4
Walleye Capital
Walleye Capital
New York
-$450K
5
Morgan Stanley
Morgan Stanley
New York
-$297K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$21.9M
2
$16.9M
3
$7.72M
4
$5.68M
5
$4.96M
6
$4.34M
7
$4.2M
8
$4M
9
$3.32M
10
$2.37M
11
$2.33M
12
$2.05M
13
$2.02M
14
$1.95M
15
$1.79M
16
$1.6M
17
$1.41M
18
$1.35M
19
$1.34M
20
$1.3M
21
$1.29M
22
$1.17M
23
$1.15M
24
$1.13M
25
$1.02M